173 related articles for article (PubMed ID: 12241125)
1. Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated?
Boldt J
Drug Saf; 2002; 25(12):837-46. PubMed ID: 12241125
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.
Mutter TC; Ruth CA; Dart AB
Cochrane Database Syst Rev; 2013 Jul; (7):CD007594. PubMed ID: 23881659
[TBL] [Abstract][Full Text] [Related]
3. [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].
Suttner S; Boldt J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):71-7. PubMed ID: 14767795
[TBL] [Abstract][Full Text] [Related]
4. PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate.
Boldt J
Intensive Care Med; 2009 Aug; 35(8):1331-6. PubMed ID: 19533094
[TBL] [Abstract][Full Text] [Related]
5. Association of high volumes of hydroxyethyl starch with acute kidney injury in elderly trauma patients.
Leberle R; Ernstberger A; Loibl M; Merkl J; Bunz M; Creutzenberg M; Trabold B
Injury; 2015 Jan; 46(1):105-9. PubMed ID: 25240412
[TBL] [Abstract][Full Text] [Related]
6. Modern rapidly degradable hydroxyethyl starches: current concepts.
Boldt J
Anesth Analg; 2009 May; 108(5):1574-82. PubMed ID: 19372338
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.
Dart AB; Mutter TC; Ruth CA; Taback SP
Cochrane Database Syst Rev; 2010 Jan; (1):CD007594. PubMed ID: 20091640
[TBL] [Abstract][Full Text] [Related]
8. [Hydroxyethylstarch (HES)].
Boldt J
Wien Klin Wochenschr; 2004 Mar; 116(5-6):159-69. PubMed ID: 15088990
[TBL] [Abstract][Full Text] [Related]
9. Effects of hydroxyethyl starch administration on renal function in critically ill patients.
Sakr Y; Payen D; Reinhart K; Sipmann FS; Zavala E; Bewley J; Marx G; Vincent JL
Br J Anaesth; 2007 Feb; 98(2):216-24. PubMed ID: 17251213
[TBL] [Abstract][Full Text] [Related]
10. An international view of hydroxyethyl starches.
Treib J; Baron JF; Grauer MT; Strauss RG
Intensive Care Med; 1999 Mar; 25(3):258-68. PubMed ID: 10229159
[TBL] [Abstract][Full Text] [Related]
11. Molecular weight and molar substitution are more important in HES-induced renal impairment than concentration after hemorrhagic and septic shock.
Simon TP; Thiele C; Schuerholz T; Fries M; Stadermann F; Haase G; Amann KU; Marx G
Minerva Anestesiol; 2015 Jun; 81(6):608-18. PubMed ID: 25296880
[TBL] [Abstract][Full Text] [Related]
12. Plasma substitutes.
Boldt J; Suttner S
Minerva Anestesiol; 2005 Dec; 71(12):741-58. PubMed ID: 16288182
[TBL] [Abstract][Full Text] [Related]
13. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.
Schortgen F; Lacherade JC; Bruneel F; Cattaneo I; Hemery F; Lemaire F; Brochard L
Lancet; 2001 Mar; 357(9260):911-6. PubMed ID: 11289347
[TBL] [Abstract][Full Text] [Related]
14. Effects of Hydroxyethyl Starch 130/0.4 on Serum Creatinine Concentration and Development of Acute Kidney Injury in Nonazotemic Cats.
Sigrist NE; Kälin N; Dreyfus A
J Vet Intern Med; 2017 Nov; 31(6):1749-1756. PubMed ID: 28862347
[TBL] [Abstract][Full Text] [Related]
15. Retrospective cohort study on the incidence of acute kidney injury and death following hydroxyethyl starch (HES 10% 250/0.5/5:1) administration in dogs (2007-2010).
Hayes G; Benedicenti L; Mathews K
J Vet Emerg Crit Care (San Antonio); 2016; 26(1):35-40. PubMed ID: 26587795
[TBL] [Abstract][Full Text] [Related]
16. Is the literature inconclusive about the harm from HES? No.
Wiedermann CJ; Bellomo R; Perner A
Intensive Care Med; 2017 Oct; 43(10):1523-1525. PubMed ID: 27007101
[No Abstract] [Full Text] [Related]
17. Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.
Kammerer T; Klug F; Schwarz M; Hilferink S; Zwissler B; von Dossow V; Karl A; Müller HH; Rehm M
Trials; 2015 Aug; 16():384. PubMed ID: 26314293
[TBL] [Abstract][Full Text] [Related]
18. Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury.
Boussekey N; Darmon R; Langlois J; Alfandari S; Devos P; Meybeck A; Chiche A; Georges H; Leroy O
Crit Care; 2010; 14(2):R40. PubMed ID: 20298543
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
Godet G
Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526922
[No Abstract] [Full Text] [Related]
20. Effect of Hydroxyethyl Starch Solution on Incidence of Acute Kidney Injury in Patients Suffering from Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage.
Kieninger M; Unbekannt D; Schneiker A; Sinner B; Bele S; Prasser C
Neurocrit Care; 2017 Feb; 26(1):34-40. PubMed ID: 27059048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
